Iovance (IOVA) Soars 33%, Hits All-Time High [Yahoo! Finance]
Iovance Biotherapeutics, Inc. (IOVA)
Last iovance biotherapeutics, inc. earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
iovance.com
Company Research
Source: Yahoo! Finance
Iovance soared by 32.9 percent week-on-week to hit a new all-time high after an analyst doubled its price target for the stock, while investors loaded portfolios ahead of business updates next week. In its market report, investment firm UBS raised its price target for Iovance Biotherapeutics Inc. (NASDAQ:IOVA) to $4 from $2 previously, but maintained a “neutral” stance on its stock. Photo from Iovance Biotherapeutics website The coverage came ahead of the biopharmaceutical firm's participation in Barclays' 28th Annual Global Healthcare Conference on Wednesday, March 11, where investors will watch out for cues and company developments to support buying appetite. In other news, Iovance Biotherapeutics Inc. (NASDAQ:IOVA) recently reported a 5 percent wider net loss last year, at $390.98 million versus $372 million in 2024. Total revenues, on the other hand, jumped by 60.6 percent to $263.5 million from $164.07 million year-on-year. In the fourth quarter alone, net loss narrowe
Show less
Read more
Impact Snapshot
Event Time:
IOVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IOVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IOVA alerts
High impacting Iovance Biotherapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
IOVA
News
- Iovance Biotherapeutics (IOVA) Announces Positive Early Data for Lifileucel TIL Therapy in Advanced Sarcomas [Yahoo! Finance]Yahoo! Finance
- Iovance Sarcoma Trial Data Puts TIL Platform And Stock In Focus [Yahoo! Finance]Yahoo! Finance
- Iovance (IOVA) Hits 52-Week High as Analyst Doubles Price Target [Yahoo! Finance]Yahoo! Finance
- UBS Raises PT on Iovance Biotherapeutics (IOVA) [Yahoo! Finance]Yahoo! Finance
- Iovance Biotherapeutics: The High-Risk Cancer Stock I Think Could Change a Portfolio by 2036 [Yahoo! Finance]Yahoo! Finance
IOVA
Earnings
- 2/24/26 - Beat
IOVA
Sec Filings
- 3/11/26 - Form 4
- 3/11/26 - Form 4
- 3/11/26 - Form 4
- IOVA's page on the SEC website